Quantitative Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Quantitative Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-41,200	Closed	-$454K	–	893
2018 Q4	$454K	Buy	+41,200	New	+$573K	0.02%	391
2018 Q3	–	Sell	-13,000	Closed	-$265K	–	972
2018 Q2	$265K	Sell	13,000 -13,000	-50%	-$279K	0.01%	677
2018 Q1	$471K	Buy	+26,000	New	+$433K	0.01%	659

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Quantitative Investment Management's MNTA Position: Q1 2019 in Review

Quantitative Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2019, closing a stake of 41,200 shares — an estimated $454K sold.

Quantitative Investment Management first reported a position in MNTA in Q1 2018 and held it in 3 quarters. The position peaked at $471K in Q1 2018. 147 funds tracked by Wall St. Rank hold MNTA as of Q1 2019.

Quantitative Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
Quantitative Investment Management sold 41,200 Momenta Pharmaceuticals, Inc. shares in Q1 2019, an estimated $454K.
Quantitative Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 3 quarters.
Quantitative Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $471K in Q1 2018.
147 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2019.

Based on Quantitative Investment Management's 13F filing for Q1 2019, filed 15 May 2019.